Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes

Annals of Noninvasive Electrocardiology

Volumn 6, Issue 1, 2001, Pages 64-75

  Savonitto, Stefano ^a,e   Fusco, Rossana ^b   Granger, Christopher B ^c   Cohen, Mauricio G ^d   Thompson, Trevor D ^b   Ardissino, Diego ^a   Califf, Robert M ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d Ospedali Riuniti di Parma   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Acute coronary syndromes; Electrocardiogram; Multivariate analysis; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION; T WAVE;

EID: 0035127843     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474x.2001.tb00088.x     Document Type: Article

References (66)

1. Determinants of 6-month mortality in survivors of MI after thrombolysis. Results of the GISSI-2 data base
2. Predictors of 30-day mortality in the era of reperfusion for acute MI: Results from an international trial of 41021 patients
3. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes
4. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
5. Effects of recombinant hirudin (lepirudin) compared with heparin on death, MI, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation: A randomized trial
6. Indications for fibrinolytic therapy in suspected acute MI: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
7. Clinical presentation and diagnostic techniques
8. The Q-wave and non-Q wave MI: Differences and similarities
9. Nomenclature and criteria for diagnosis of ischemic heart disease
10. International diagnostic criteria for acute MI and acute stroke
11. Acute coronary syndromes in the GUSTO-IIb trial. Prognostic insights and impact of recurrent ischemia
12. Even minor elevations of creatine kinase predict increased risk of cardiac events in acute coronary syndromes without ST-segment elevation
13. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation
14. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute MI. Analysis of 28 months of follow-up in 196 patients
15. Prognostic value of the admission ECG in acute coronary syndromes. Results from the GUSTO-IIb trial
16. The non Q wave MI revisited: 10 years later
17. Prognostic significance of the admission electrocardiogram in acute MI
18. Single bolus tenecteplase compared with front-loaded alteplase in acute MI: The ASSENT-2 double-blind randomized trial
19. Clinical characteristics and outcome of acute MI in patients with initially normal or nonspecific ECGs (a report from the Multicenter Chest Pain Study)
20. Bundle-branch block and in-hospital mortality in acute MI
21. Acute MI and complete bundle branch block at hospital admission. Clinical characteristics and outcome in the thrombolytic era
22. Incidence, clinical characteristics, and prognostic significance of right bundle-branch block in acute MI
23. Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy
24. Prognostic significance of the initial electrocardiogram in patients with acute MI
25. Prognostic significance of precordial ST segment depression during inferior MI in the thrombolytic era: Results in 16,521 patients
26. Prognostic significance of precordial ST segment depression on admission electrocardiogram on patients with inferior wall MI
27. Prognostic significance of the extent of myocardial injury in acute MI treated by streptokinase (the GISSI trial)
28. Prognostic significance of the admission electrocardiogram in acute MI
29. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
30. Consequences of reocclusion after successful reperfusion therapy in acute MI
31. Risk stratification with a bedside cardiac troponin T test in 12,000 patients with ST-segment elevation MI: A GUSTO-III substudy
32. Diagnosing and managing unstable angina
33. Management of acute coronary syndromes based on risk stratification. An idea whose time has come
34. Very early risk stratification using combined biochemical assessment in patients with unstable coronary artery disease (a thrombin inhibition in myocardial ischemia [TRIM] substudy)
35. Sex differences in evaluation and outcome in unstable angina
36. Outcome and profile of women and men presenting with acute coronary syndromes: A report from TIMI IIIB
37. Sex, clinical presentation, and outcome in patients with acute coronary syndromes
38. Unstable angina. A classification
39. Incidence and follow-up of Braunwald subgroups in unstable angina pectoris
40. Risk stratification in unstable angina: Prospective validation of the Braunwald classification
41. Invasive compared with noninvasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicenter study
42. Acute chest pain in the emergency room. Identification and examination of low-risk patients
43. Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease
44. Prediction of the need for intensive care in patients who come to emergency departments with acute chest pain
45. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings
46. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q-wave MI: Results of the TIMI III registry ECG ancillary study
47. Anatomic and prognostic significance of new T-wave inversion in unstable angina
48. Diagnostic and prognostic implications of transient isolated negative T waves in suspected acute MI
49. Positivization of T wave with or without ST segment elevation in patients with unstable angina. Coronary angiographic findings and in-hospital prognosis
50. Clinical presentation and diagnostic techniques
51. Short- and long-term clinical outcome after Q wave and non-Q wave MI in a large patient population
52. Clinical and angiographic findings in angina at rest
53. Patients with suspected MI who present with ST depression
54. Unstable angina: The significance of ST segment elevation or depression in patients without evidence of increased myocardial oxygen demand
55. Quantitative electrocardiographic variables predict adverse outcomes in non-ST elevation acute coronary syndromes: Results from GUSTO IIb
56. The prognostic value of serum troponin T in unstable angina
57. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
58. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes
59. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
60. Ruling out a MI early with two serial creatine kinase-MB mass determinations
61. mass
62. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
63. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial function
64. Novel inflammatory markers of coronary risk. Theory versus practice
65. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients
66. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: Additional prognostic information from continuous ST segment monitoring